Clinical features of vitiligo linked to age of disease onset

January 9, 2017

(HealthDay)—The clinical features of vitiligo are associated with age of disease onset, according to a study published online Jan. 4 in the International Journal of Dermatology.

Berna Solak, M.D., from Sakarya University in Turkey, and colleagues examined the demographic and clinical features of patients with non-segmental vitiligo and the correlation between vitiligo and . Data were retrospectively evaluated for 224 vitiligo patients with complete medical records.

The researchers found that children had significantly higher prevalence of halo nevi than among other patient groups. Adults with adult-onset disease had higher prevalence of leukotrichia than pediatric patients or adults with childhood-onset disease. Adults with adult-onset disease had significantly higher levels of anti-thyroglobulin (TG) and anti-thyroid peroxidase than and adults with childhood-onset disease. Autoimmune disease prevalence was 22.2 percent. Patients with treatment-related regimentation had significantly higher anti-TG levels than those without repigmentation.

"This study shows that clinical features and associations with autoimmune disease may vary according to the age of onset of ," the authors write.

Explore further: Prevalence, risk of thyroid disease up in vitiligo patients

More information: Full Text (subscription or payment may be required)

Related Stories

Prevalence, risk of thyroid disease up in vitiligo patients

August 13, 2012

(HealthDay) -- Both the prevalence and the risk of thyroid diseases are significantly higher among patients with vitiligo compared to those without the condition, according to a study published online Aug. 3 in the British ...

Researchers identify genes related to vitiligo

October 10, 2016

For the past decade, Richard Spritz's lab at the University of Colorado Anschutz Medical Campus has been searching for potential causes of vitiligo, an autoimmune disease that gives rise to patches of white skin and hair.

Recommended for you

$460-mn vaccine push to 'outsmart' viruses

January 19, 2017

With the world still reeling from outbreaks of deadly Ebola and baby-deforming Zika, governments and charities launched a $460-million (431 million-euro) initiative Thursday to "outsmart" infectious epidemics.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.